Pharmaceutical Companies Race to Develop COVID-19 Antiviral Pill: Will it Work?

Seeing huge progress in vaccine technology and development, there's more hope in speeding up antiviral pipelines through development of working Covid-19 pills. In fact, Merck & Co., Inc., an American multinational pharmaceutical company, anticipates authorization for its oral COVID-19 antiviral drug, molnupiravir, by the end of the year, November as earliest.